Wall Street News Alert -- Stock Focus List! April 7, 2004


WESTON, Fla., April 7, 2004 (PRIMEZONE) -- Wall Street News Alert's "stocks to watch" this morning are: 12 to 20 Plus Inc. (OTCBB:TTTP), Advanced Optics Electronics (OTCBB:ADOT), Ezenia! Inc. (OTCBB:EZEN) and Generex Biotechnology (Nasdaq:GNBT).

Aggressive investors need to look at 12 to 20 Plus Inc. (OTCBB:TTTP) this morning! Yesterday after the markets closed, the company issued a press release announcing that it has acquired the rights to market "HydroCap+(tm)"; a product created specifically for American and allied forces operating in desert environments and humid tropical locations around the world!

This could be big news to investors! According to the press release, an additional market includes those millions of Americans that work or exercise in conditions where the body is strained by heat and the loss of valuable nutrients and electrolytes. 12 to 20 Plus, Inc. is poised to penetrate this multi-million dollar market with HydroCap, a nutritional product essential to replenishment of all metabolic losses, including electrolytes that occur during thermal dehydration or heat stress, provides nutrients appropriate to the restoration of electrolytes and water balance and energy recovery. HydroCap is the only product to address these total body requirements.

Supported by military food scientists, a well nourished solider is important to all military operations. The addition of HydroCap as a preventative against dehydration to the military menu should prove to have a scientifically positive impact on health, well being and performance. The product's creator, Dr. John Hewitt, a former organic research chemist for duPont, says, "We feel it is essential to personnel, second only to water and shade." HydroCap is an easily swallowed vanilla-coated caplet taken with six ounces of fluid at each meal providing rapid rehydration of lost body fluid to tissues.

Aggressive investors should keep your eyes on this company! Carol Slavin, President of TTTP stated, "Although this product was initially developed to help insure the well being of our troops in extreme circumstances, the traditional consumer markets will be targeted as well. Active individuals participating in any sport or activity would benefit physically by adding HydroCap to their daily regime. This un-tapped market could be worth millions of dollars in revenues to the company as we go forward with distribution."

The stock closed at eighteen cents a share yesterday.

In case you are not familiar with the company: 12 to 20 Plus, Incorporated is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional formulas and nutraceuticals. One of the company's flagship products, the Zit Stick(r), is a "spa style" acne therapy system(tm). The market for acne remedies is expected to reach $370 million in 2004. 12 to 20 Plus, Inc. also markets highly effective condition-specific dietary supplements containing the most sophisticated combination of extensively researched nutritional elements available. The products are manufactured by FDA-approved labs and do not contain herbs. Instead, the company utilizes potent pharmaceutical grade "amino acids" and important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. Some of (NRG) products include Anaplex (tm), a antidepressant drug alternative; VisionKare(tm), an advanced supplement for macular degeneration; ChemoKare(tm), a unique combination of extracts designed to treat the side effects of chemotherapy; QuitSystem(r), a neuronutrient supplementation for recovery from alcohol, drugs and smoking; Hinoki Bana(tm), a treatment for men and women with hair loss problems. Retail sales in the explosive dietary supplement market are expected to hit $21 billion by year 2007, according to Frost & Sullivan reports.

Stocks showing interesting activity yesterday were: Advanced Optics Electronics (OTCBB:ADOT) down 14% on 73.1 million shares traded, Ezenia! Inc. (OTCBB:EZEN) up 43.3% on 1.2 million shares traded and Generex Biotechnology (Nasdaq:GNBT) up 13.6% on 2.1 million shares traded.

Commentary:

"Factory orders rose by 0.3% in February and the global economy is estimated to grow 4.75% in 2004 and at 4.0% for 2005, this news from a Washington think tank," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at: http://www.WallStreetNewsAlert.com.

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 16 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated two hundred thousand shares of 12 to 20 Plus Inc. (OTCBB:TTTP), by a third party (Venture Capital Resource, Ltd.), who is non-affiliated and may hold a significant position in the stock, for services provided including dissemination of company information in this release. WSCF has not sold any of those shares, as of this release. WSCF may intend to immediately begin or continue selling its shares as this release is being circulated. WSCF may receive additional shares for extension of its services. Any additional shares will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock. Market commentary provided by Sonja Rudd.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.



            

Contact Data